Back
Intellia Therapeutics Stock Price Chart
The little-known AI stock you need to read about now...
Get the name - FREE.
Sell
20
NTLA
Intellia Therapeutics
Last Price:
21.33
Seasonality Move:
34.64%
7 Day Trial
ALL ACCESS PASS
$
7
DeFi Coin Triggers All "Buy" Signals And Could Break Out Soon
Discover our top DeFi pick for potentially massive gains now (before it's too late).- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NTLA is experiencing selling pressure, which indicates risk of future bearish movement.
Intellia Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 23.98 | Sell |
| 20-day SMA: | 25.44 | Sell |
| 50-day SMA: | 27.41 | Sell |
| 200-day SMA: | 31.34 | Sell |
| 8-day EMA: | 23.49 | Sell |
| 20-day EMA: | 25.09 | Sell |
| 50-day EMA: | 26.63 | Sell |
| 200-day EMA: | 31.32 | Sell |
Intellia Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.42 | Sell |
| Relative Strength Index (14 RSI): | 27.12 | Sell |
| Chaikin Money Flow: | -876127 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (24.05 - 27.81) | Sell |
| Bollinger Bands (100): | (25.52 - 30.6) | Sell |
Intellia Therapeutics Technical Analysis
| Apr 4 | Apr 5 | Apr 8 | Apr 9 | Apr 10 | Apr 11 | Apr 12 | Apr 15 | Apr 16 | Apr 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 04 | 05 | 08 | 09 | 10 | 11 | 12 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Intellia Therapeutics Stock
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 21.50 while NTLA 8-day simple moving average is 23.98, which is a Sell signal.
- The stock price of NTLA is 21.50 while Intellia Therapeutics 20-day SMA is 25.44, which makes it a Sell.
- Intellia Therapeutics 50-day simple moving average is 27.41 while NTLA share price is 21.50, making it a Sell technically.
- NTLA stock price is 21.50 and Intellia Therapeutics 200-day simple moving average is 31.34, creating a Sell signal.
NTLA Technical Analysis vs Fundamental Analysis
Sell
20
Intellia Therapeutics (NTLA)
is a Sell
Is Intellia Therapeutics a Buy or a Sell?
-
Intellia Therapeutics stock is rated a Sell
The current Intellia Therapeutics [NTLA] share price is $21.50. The Score for NTLA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
Intellia Therapeutics Stock Info
Market Cap:
2.07B
Price in USD:
21.50
Share Volume:
1.06M
Intellia Therapeutics 52-Week Range
52-Week High:
47.48
52-Week Low:
21.80
Sell
20
Intellia Therapeutics (NTLA)
is a Sell
Intellia Therapeutics Share Price Forecast
-
What is the Intellia Therapeutics stock price today?
The Intellia Therapeutics stock price is 21.50 USD today. -
Will NTLA stock go up or go down?
Intellia Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Intellia Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Intellia Therapeutics is overvalued.
Is Intellia Therapeutics Stock a Buy?
- Intellia Therapeutics share price is 21.50 while NTLA 8-day exponential moving average is 23.49, which is a Sell signal.
- The stock price of NTLA is 21.50 while Intellia Therapeutics 20-day EMA is 25.09, which makes it a Sell.
- Intellia Therapeutics 50-day exponential moving average is 26.63 while NTLA share price is 21.50, making it a Sell technically.
- NTLA stock price is 21.50 and Intellia Therapeutics 200-day simple moving average is 31.32, creating a Sell signal.
Fundamental Analysis of Intellia Therapeutics
Is Intellia Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.11 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.14 per share, and an increase next year of $0.02 per share.
Technical Analysis of Intellia Therapeutics
Should I short Intellia Therapeutics stock?
- NTLA Moving Average Covergence Divergence (MACD) indicator is -1.42, suggesting Intellia Therapeutics is a Sell
- Intellia Therapeutics Relative Strength Index (RSI) is 27.12, which suggest Intellia Therapeutics is oversold
- The Bollinger Bands (25) for Intellia Therapeutics is (24.05 - 27.81), which suggest Intellia Therapeutics is a Sell
- The Bollinger Bands (100) for Intellia Therapeutics is (25.52 - 30.6), which suggest Intellia Therapeutics is a Sell
* Intellia Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.